Uncovering a healthier remedy for chronic pain
Physicians and patients who are wary of addiction to pain medication and opioids may soon have a healthier and more natural alternative.
Physicians and patients who are wary of addiction to pain medication and opioids may soon have a healthier and more natural alternative.
A review of the presentation by Professor David Cunningham (pictured), London, UK. The risk profile of rectal tumours varies with the position and profile of the disease. David… read more.
Review of the presentation by HJ Schmoll EORTC GI Group. [Preoperative chemoradiotherapy with capecitabine and oxaliplatin vs capecitabine alone in locally advanced rectal cancer: response to the local treatment… read more.
A review of the presentation by Rene Adam MD (pictured). There has been considerable progress in the overall survival of patients with colorectal cancer taking chemotherapy.
by Pam Harrison – MSI status has clear prognostic value in stage II CRC Julien Taieb, MD, PhD, University of Paris Descartes, Paris, France Microsatellite instability (MSI), a… read more.
FDA Highlights by Bruce Sylvester – Researchers report from a phase I clinical trial report that diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy have been successfully reprogrammed… read more.
Johns Hopkins researchers see 21-fold increase in a single day. A social media push boosted the number of people who registered themselves as organ donors 21-fold in a… read more.
Dr Erin Dunbar, Assistant Professor and Co. Director, Preston A. Wells, Jr. Center for Brain Tumor Therapy, Department of Neurosurgery, University of Florida.
A new study reveals significant hospital-to-hospital variability in patient death rates following emergency surgical admissions in England. Published early online in the BJS (British Journal of Surgery), the study also… read more.
A review of the presentation by Jaume Capdevila, Barcelona Spain. Unfortunately Neuroendocrine tumours (NETs) are often advanced at the time of diagnosis and the 5 year survival ranges… read more.
Poster 67 Elizabeth Goode elizabeth.goode@nnuh.nhs.uk. Chemotherapy is an independent risk factor for thromboembolism (TE), although current guidelines do not recommend routine use of anti-thrombin agents in this setting.
Taken from the NEJM – by Bruce Sylvester – Three biomarkers in the urine of kidney transplant recipients can be used to diagnose and predict transplant rejection, researchers… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.